文献速递胸部肿瘤放疗放疗物理与技术

基于稳健4DCT通气与灌注成像预测肺癌患者放射性肺炎

Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging.
PubMed 文献 · Radiother Oncol · 2025-09-01

本研究利用多中心二期临床试验中63例晚期肺癌患者的前瞻性数据,评估新型4DCT通气与灌注成像方法预测≥2级放射性肺炎的能力。结果显示基于质量守恒体积变化的4DCT通气(4DCT-vent-MCVC)在逻辑回归和机器学习模型中预测性能最佳,机器学习模型AUC达0.83±0.04。

要点

  • 63例晚期肺癌患者中10例(15.9%)发生≥2级放射性肺炎。
  • 4DCT-vent-MCVC在逻辑回归中AUC为0.70±0.02(p=0.04),优于传统指标。
  • 机器学习模型中4DCT-vent-MCVC的AUC最高,达0.83±0.04。

核心结论

  • 在63例患者中,4DCT-vent-MCVC是预测放射性肺炎的最佳指标。

研究设计与样本

  • 研究纳入多中心二期临床试验中63例接受4DCT功能回避放疗的晚期肺癌患者。
  • 基于4DCT生成四种肺功能图像:传统HU法通气、MCVC通气、IJF通气和4DCT灌注。
  • 采用逻辑回归和机器学习评估剂量-功能指标预测≥2级放射性肺炎的能力,并以10折交叉验证评估模型性能。

主要发现

  • 10/63(15.9%)患者发生≥2级放射性肺炎。
  • 逻辑回归中4DCT-vent-MCVC的AUC为0.70±0.02(p=0.04),4DCT-perfusion为0.64±0.04(p=0.13),4DCT-vent-IJF为0.60±0.03(p=0.27),4DCT-vent-HU为0.63±0.03(p=0.20),标准肺指标为0.65±0.10(p>0.05)。
  • 机器学习模型中4DCT-vent-MCVC、4DCT-perfusion、4DCT-vent-IJF、4DCT-vent-HU和标准肺指标的AUC分别为0.83±0.04、0.82±0.05、0.76±0.05、0.74±0.06和0.75±0.02,准确率75-85%。

关键数值与推荐

  • 剂量-功能指标包括平均功能性肺剂量(fMLD)及功能肺接受≥5 Gy(fV5)和≥20 Gy(fV20)的体积百分比。
  • 预测终点为≥2级放射性肺炎。

临床怎么用

  • 4DCT-vent-MCVC可用于评估肺癌放疗患者发生≥2级放射性肺炎的风险。
  • 机器学习模型结合4DCT功能成像可提升预测性能。

局限性

  • 研究样本量较小(63例),事件数较少(10例≥2级放射性肺炎)。
  • 结论基于该特定队列的逻辑回归和机器学习分析,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Methods have been developed that apply image processing to 4-Dimension computed tomography (4DCT) to generate lung ventilation (4DCT-ventilation). Traditional methods for 4DCT-ventilation rely on density-change methods and lack reproducibility and do not provide 4DCT-perfusion data. Novel 4DCT-ventilation/perfusion methods have been developed that are robust and provide 4DCT-perfusion information. The purpose of this study was to use prospective clinical trial data to evaluate the ability of novel 4DCT-based lung function imaging methods to predict pneumonitis. MATERIALS AND METHODS: Sixty-three advanced-stage lung cancer patients enrolled in a multi-institutional, phase 2 clinical trial on 4DCT-based functional avoidance radiation therapy were used. 4DCTs were used to generate four lung function images: (1) 4DCT-ventilation using the traditional HU approach ('4DCT-vent-HU'), and 3 methods using the novel statistically robust methods: (2) 4DCT-ventilation based on the Mass Conserving Volume Change ('4DCT-vent-MCVC'), (3) 4DCT-ventilation using the Integrated Jacobian Formulation ('4DCT-vent-IJF') and 4) 4DCT-perfusion. Dose-function metrics including mean functional lung dose (fMLD), and percentage of functional lung receiving ≥5 Gy (fV5), and ≥20 Gy (fV20) were calculated using various structure-based thresholds. The ability of dose-function metrics to predict for ≥grade 2 RP was assessed using logistic regression and machine learning. Model performance was evaluated using the area under the curve (AUC) and validated through 10-fold cross-validation. RESULTS: 10/63 (15.9 %) patients developed grade ≥2 RP. Logistic regression yielded mean AUCs of 0.70 ± 0.02 (p = 0.04), 0.64 ± 0.04 (p = 0.13), 0.60 ± 0.03 (p = 0.27), and 0.63 ± 0.03 (p = 0.20) for 4DCT-vent-MCVC, 4DCT-perfusion, 4DCT-vent-IJF, and 4DCT-vent-HU, respectively, compared to 0.65 ± 0.10 (p > 0.05) for standard lung metrics. Machine learning modeling resulted in AUCs 0.83 ± 0.04, 0.82 ± 0.05, 0.76 ± 0.05, 0.74 ± 0.06, and 0.75 ± 0.02 for 4DCT-vent-MCVC, 4DCT-perfusion, 4DCT-vent-IJF, and 4DCT-vent-HU, and standard lung metrics respectively, with an accuracy of 75-85 %. CONCLUSIONS: This is the first study to comprehensively evaluate 4DCT-perfusion and robust 4DCT-ventilation in predicting clinical outcomes. The data showed that on the presented 63-patient study and using classis logistic regression and ML methods, 4DCT-vent-MCVC was the best predictors of RP.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Neupane T, Castillo E, Chen Y, et al. Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging. Radiother Oncol. 2025. PMID: 40902906. doi:10.1016/j.radonc.2025.111110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。